These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 156427)

  • 41. Statistics of 416 consecutive kidney transplants in the France Transplant organization.
    Dausset J; Hors J
    Transplant Proc; 1973 Mar; 5(1):223-9. PubMed ID: 4121169
    [No Abstract]   [Full Text] [Related]  

  • 42. Analysis of immunomodulation induced by donor-specific blood transfusion (DST): establishment of a human-mouse hybridoma secreting the MLR inhibiting factor.
    Kawamura T; Sakagami K; Orita K
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1802-5. PubMed ID: 2523592
    [No Abstract]   [Full Text] [Related]  

  • 43. The relationship between lymphokine responsiveness and HLA DR antigens as prognostic indicators of renal transplant survival.
    MacSween JM; Eastwood SL; Cohen AD; Rajaraman K
    Transplantation; 1986 Apr; 41(4):534-6. PubMed ID: 3515654
    [No Abstract]   [Full Text] [Related]  

  • 44. Effect of matching for DR antigens and pretransplant blood transfusions on kidney graft survival in rhesus monkeys.
    Borleffs JC; Marquet RL; Neuhaus P
    Transplant Proc; 1982 Jun; 14(2):403-6. PubMed ID: 6214065
    [No Abstract]   [Full Text] [Related]  

  • 45. Donor-specific hyporesponsiveness is observed in renal transplant patients who successfully maintain their renal function more than 6 years.
    Kim YK; Ha J; Park MH; Kim SJ
    Transplant Proc; 1996 Jun; 28(3):1235-6. PubMed ID: 8658639
    [No Abstract]   [Full Text] [Related]  

  • 46. A sensitive technique for measuring specific macrophage aggregation: a comparison with macrophage migration inhibition, for the detection of lymphokine activity.
    Rouveix B; Badenoch-Jones P; Turk JL
    Immunology; 1979 Mar; 36(3):589-94. PubMed ID: 374256
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Inhibition of mixed lymphocyte culture by alloantibodies in renal transplantation and in pregnancy.
    Revillard JP; Robert M; DuPont E; Betuel H; Rifle G; Traeger J
    Transplant Proc; 1973 Mar; 5(1):331-5. PubMed ID: 4266656
    [No Abstract]   [Full Text] [Related]  

  • 48. The detection and measurement of pretransplant sensitization.
    Carpenter CB; Morris PJ
    Transplant Proc; 1978 Jun; 10(2):509-13. PubMed ID: 150085
    [No Abstract]   [Full Text] [Related]  

  • 49. Study of the effect of HLA class II antigens (serotyping and mixed lymphocyte reaction) on kidney graft outcome.
    Ichikawa Y; Hashimoto M; Sata M; Fujimoto N; Kinoshita T; Kyo M; Kanda H; Ishibashi M; Fukunishi T; Amemiya H
    Transplant Proc; 1993 Aug; 25(4):2710-2. PubMed ID: 8356725
    [No Abstract]   [Full Text] [Related]  

  • 50. Rapid mixed lymphocyte culture (MLC)--an aid for selection of recipients of cadaveric renal allografts.
    Butt KM; Glass NR; Parsa I; Rao TK; Adamsons RJ; Kountz SL
    Transplant Proc; 1979 Mar; 11(1):763-6. PubMed ID: 156434
    [No Abstract]   [Full Text] [Related]  

  • 51. Mechanisms of prolongation of graft survival.
    Carpenter CB
    Transplant Proc; 1979 Dec; 11(4):1885-8. PubMed ID: 161100
    [No Abstract]   [Full Text] [Related]  

  • 52. [Significance of mixed lymphocyte culture (MLC) in renal transplants from living donors].
    Zanuso C; Pontiero P; Ancona G; Galvani E; Confortini P
    Minerva Chir; 1980 May; 35(10):791-2. PubMed ID: 6450337
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Reappraisal of HLA antibody analysis and crossmatching in kidney transplantation.
    Lee PC; Ozawa M
    Clin Transpl; 2007; ():219-26. PubMed ID: 18642453
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Improved renal allograft survival for AHG and DTE/AHG crossmatch-negative recipients.
    Kerman RH; Kimball PM; Van Buren CT; Lewis RM; DeVera V; Baghdahsarian V; Heydari A; Kahan BD
    Transplant Proc; 1991 Feb; 23(1 Pt 1):400-2. PubMed ID: 1990565
    [No Abstract]   [Full Text] [Related]  

  • 55. Human donor bone marrow cells can enhance hyporeactivity in renal transplantation using maintenance FK 506 and OKT3 induction therapy.
    Ciancio G; Carreno M; Mathew J; Ricordi C; Garcia R; Karatzas T; Fuller L; Cirocco R; Burke G; Webb M; Nery J; Tzakis A; Roth D; Esquenazi V; Miller J
    Transplant Proc; 1996 Apr; 28(2):943-4. PubMed ID: 8623473
    [No Abstract]   [Full Text] [Related]  

  • 56. LD-SD interaction in vivo and the allograft reaction.
    van Rood JJ
    Transplant Proc; 1973 Dec; 5(4):1747-50. PubMed ID: 4272829
    [No Abstract]   [Full Text] [Related]  

  • 57. Histocompatibility testing in clinical renal transplantation.
    Braun WE
    Urol Clin North Am; 1983 May; 10(2):231-42. PubMed ID: 6222529
    [No Abstract]   [Full Text] [Related]  

  • 58. Evidence for a suppressor cell system in human kidney allograft tolerance.
    Charpentier B; Lang P; Martin B; Fries D
    Transplant Proc; 1981 Mar; 13(1 Pt 1):90-4. PubMed ID: 6455811
    [No Abstract]   [Full Text] [Related]  

  • 59. Phenotypic expression of the main histocompatibility complex (DL-A) in randomly selected mongrel dogs. 3. Inhibition of the mixed leukocyte culture reaction during and after sensitization to skin allografts.
    Bachvaroff R; Ozaki A; Cannon FD; Mollen N; Blumenstock DA; Ayvazian JH; Ferrebee JW; Rapaport FT
    Transplant Proc; 1973 Dec; 5(4):1863-8. PubMed ID: 4272835
    [No Abstract]   [Full Text] [Related]  

  • 60. B lymphocyte crossmatching: lack of effect on transplant outcome based on incubation temperature.
    Ettenger RB; Malekzadeh MH; Pennisi AJ; Uittenbogaart CH; Jordan SC; Fine RN
    Proc Clin Dial Transplant Forum; 1979; 9():197-200. PubMed ID: 399506
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.